Analytical Data
-
基因名
PSMA4
- Application
-
别名
PSMA4;HC9;PSC9;Proteasome subunit alpha type-4
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P25789
-
表达区间
1-261aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MGSHMSLQYG AEETPLAGSY GAADSFPKDF GYGVEEEEEE AAAAGGGVGA GAGGGCGPGG ADSSKPRILL MGLRRSGKSS IQKVVFHKMS PNETLFLEST NKIYKDDISN SSFVNFQIWD FPGQMDFFDP TFDYEMIFRG TGALIYVIDA QDDYMEALTR LHITVSKAYK VNPDMNFEVF IHKVDGLSDD HKIETQRDIH QRANDDLADA GLEKLHLSFY LTSIYDHSIF EAFSKVVQKL IPQLPTLENL LNIFISNSGI EKAFLFDVVS KIYIATDSSP VDMQSYELCC DMIDVVIDVS CIYGLKEDGS GSAYDKESMA IIKLNNTTVL YLKEVTKFLA LVCILREESF ERKGLIDYNF HCFRKAIHEV FEVGVTSHRS CGHQTSASSL KALTHNGTPR NAI
-
分子量
32 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PSMA4, a component of the 26S proteasome, plays a critical role in the ubiquitin-proteasome pathway, which is essential for protein degradation and turnover in cells. Research on PSMA4 has gained considerable attention due to its involvement in various cellular processes, including cell cycle regulation, apoptosis, and responses to stress. Dysregulation of PSMA4 has been implicated in several diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. Studies have shown that PSMA4 is not only important for maintaining protein homeostasis but also influences the immune response and the processing of antigens. Consequently, understanding the structure and function of PSMA4, along with its potential as a therapeutic target, has become a significant focus in biomedical research. Recent advancements in recombinant protein technology have facilitated the production of PSMA4 for detailed studies, allowing researchers to investigate its enzymatic activity, regulatory mechanisms, and interactions with other proteins. This research not only sheds light on the fundamental biology of PSMA4 but also opens new avenues for developing targeted therapies that could mitigate the effects of diseases linked to proteasome dysfunction. As a result, PSMA4 stands at the intersection of cell biology and therapeutic innovation, making it a promising candidate for future research aimed at understanding and treating complex diseases.
